EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 372 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,885 | +11.4% | 727 | -2.5% | 0.00% | 0.0% |
| Q2 2023 | $14,256 | +5.7% | 746 | +7.3% | 0.00% | 0.0% |
| Q1 2023 | $13,490 | +2304.6% | 695 | +1885.7% | 0.00% | – |
| Q4 2022 | $561 | – | 35 | +118.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 16 | -56.8% | 0.00% | – |
| Q3 2021 | $1,000 | -75.0% | 37 | -82.9% | 0.00% | -100.0% |
| Q2 2021 | $4,000 | -20.0% | 217 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +25.0% | 217 | +11.3% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |